Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors

• Siddhi N. Paudel,
• Brian J. Hutzen,
• Katherine E. Miller,
• Katherine E. Miller,
• Elizabeth A. R. Garfinkle,
• Chun-Yu Chen,
• Pin-Yi Wang,
• Andrea M. Glaspell,
• Mark A. Currier,
• Emily M. Ringwalt,
• Louis Boon,
• Elaine R. Mardis,
• Elaine R. Mardis,
• Mitchell S. Cairo,
• Nancy Ratner,
• Rebecca D. Dodd,
• Kevin A. Cassady,
• Kevin A. Cassady,
• Timothy P. Cripe,
• Timothy P. Cripe,
• Timothy P. Cripe

Affiliations

Siddhi N. Paudel

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Brian J. Hutzen

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Katherine E. Miller

Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Katherine E. Miller

Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States

Elizabeth A. R. Garfinkle

Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Chun-Yu Chen

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Pin-Yi Wang

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Andrea M. Glaspell

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Mark A. Currier

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Emily M. Ringwalt

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Louis Boon

JJP Biologics, Warsaw, Poland

Elaine R. Mardis

Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Elaine R. Mardis

Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States

Mitchell S. Cairo

Department of Pediatrics, Medicine, Pathology, Microbiology and Immunology, and Cell Biology, New York Medical College, Valhalla, NY, United States

Nancy Ratner

Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Rebecca D. Dodd

Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States

Kevin A. Cassady

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Kevin A. Cassady

Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States

Timothy P. Cripe

Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States

Timothy P. Cripe

Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States

Timothy P. Cripe

Division of Pediatric Hematology/Oncology/BMT, Nationwide Children’s Hospital, Columbus, OH, United States